Pharmacists’ perspectives on medication reviews for long-term care residents with advanced dementia: a qualitative study

Domenica Disalvo, Tim Luckett, Alexandra Bennett, Patricia M Davidson, Meera Agar

Research output: Contribution to journalArticle

Abstract

Background Medication reviews by pharmacists have been shown to identify and reduce drug-related problems in long-term care residents. Objective To explore pharmacist perspectives of the Australian Government funded pharmacist-conducted residential medication management review and its role improving the quality and safety of prescribing in long-term care, in particular for those living with advanced dementia. Setting Australian Long-term care pharmacists. Method A qualitative research methodology approach using semi-structured interviews was used, with participants pharmacists with Residential Medication Management Review experience. Interviews were recorded, transcribed and coded utilising a meta-model of Physician-Community Pharmacy Collaboration in medication review. Main outcome measure Pharmacists’ perspectives on the Residential Medication Management Review and how to improve the quality of reviews for residents with advanced dementia. Results Fifteen accredited pharmacists participated. The majority believed that the Residential Medication Management Review had the potential to improve the quality and safety of medicines but highlighted systemic issues that worked against collaborative practice. Participants emphasised the importance of three-way collaboration between general practitioners, pharmacists and nursing staff and highlighted key strategies for its optimisation. Conclusion Incorporating avenues for greater communication between team members can improve collaboration between health professionals and ultimately the quality of medication reviews.

Original languageEnglish (US)
Pages (from-to)950-962
Number of pages13
JournalInternational Journal of Clinical Pharmacy
Volume41
Issue number4
DOIs
StatePublished - Aug 1 2019

Fingerprint

Long-Term Care
Pharmacists
Dementia
Interviews
Safety
Qualitative Research
Pharmacies
Nursing Staff
Nursing
Bioelectric potentials
General Practitioners
Research Design
Medicine
Communication
Outcome Assessment (Health Care)
Physicians
Health
Pharmaceutical Preparations

Keywords

  • Advanced dementia
  • Australia
  • Deprescribing
  • Interdisciplinary collaboration
  • Long-term care
  • Medication review
  • Palliative care

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Pharmacists’ perspectives on medication reviews for long-term care residents with advanced dementia : a qualitative study. / Disalvo, Domenica; Luckett, Tim; Bennett, Alexandra; Davidson, Patricia M; Agar, Meera.

In: International Journal of Clinical Pharmacy, Vol. 41, No. 4, 01.08.2019, p. 950-962.

Research output: Contribution to journalArticle

@article{e6c397e01675438795637e2f6bee8b9f,
title = "Pharmacists’ perspectives on medication reviews for long-term care residents with advanced dementia: a qualitative study",
abstract = "Background Medication reviews by pharmacists have been shown to identify and reduce drug-related problems in long-term care residents. Objective To explore pharmacist perspectives of the Australian Government funded pharmacist-conducted residential medication management review and its role improving the quality and safety of prescribing in long-term care, in particular for those living with advanced dementia. Setting Australian Long-term care pharmacists. Method A qualitative research methodology approach using semi-structured interviews was used, with participants pharmacists with Residential Medication Management Review experience. Interviews were recorded, transcribed and coded utilising a meta-model of Physician-Community Pharmacy Collaboration in medication review. Main outcome measure Pharmacists’ perspectives on the Residential Medication Management Review and how to improve the quality of reviews for residents with advanced dementia. Results Fifteen accredited pharmacists participated. The majority believed that the Residential Medication Management Review had the potential to improve the quality and safety of medicines but highlighted systemic issues that worked against collaborative practice. Participants emphasised the importance of three-way collaboration between general practitioners, pharmacists and nursing staff and highlighted key strategies for its optimisation. Conclusion Incorporating avenues for greater communication between team members can improve collaboration between health professionals and ultimately the quality of medication reviews.",
keywords = "Advanced dementia, Australia, Deprescribing, Interdisciplinary collaboration, Long-term care, Medication review, Palliative care",
author = "Domenica Disalvo and Tim Luckett and Alexandra Bennett and Davidson, {Patricia M} and Meera Agar",
year = "2019",
month = "8",
day = "1",
doi = "10.1007/s11096-019-00821-7",
language = "English (US)",
volume = "41",
pages = "950--962",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Pharmacists’ perspectives on medication reviews for long-term care residents with advanced dementia

T2 - a qualitative study

AU - Disalvo, Domenica

AU - Luckett, Tim

AU - Bennett, Alexandra

AU - Davidson, Patricia M

AU - Agar, Meera

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Background Medication reviews by pharmacists have been shown to identify and reduce drug-related problems in long-term care residents. Objective To explore pharmacist perspectives of the Australian Government funded pharmacist-conducted residential medication management review and its role improving the quality and safety of prescribing in long-term care, in particular for those living with advanced dementia. Setting Australian Long-term care pharmacists. Method A qualitative research methodology approach using semi-structured interviews was used, with participants pharmacists with Residential Medication Management Review experience. Interviews were recorded, transcribed and coded utilising a meta-model of Physician-Community Pharmacy Collaboration in medication review. Main outcome measure Pharmacists’ perspectives on the Residential Medication Management Review and how to improve the quality of reviews for residents with advanced dementia. Results Fifteen accredited pharmacists participated. The majority believed that the Residential Medication Management Review had the potential to improve the quality and safety of medicines but highlighted systemic issues that worked against collaborative practice. Participants emphasised the importance of three-way collaboration between general practitioners, pharmacists and nursing staff and highlighted key strategies for its optimisation. Conclusion Incorporating avenues for greater communication between team members can improve collaboration between health professionals and ultimately the quality of medication reviews.

AB - Background Medication reviews by pharmacists have been shown to identify and reduce drug-related problems in long-term care residents. Objective To explore pharmacist perspectives of the Australian Government funded pharmacist-conducted residential medication management review and its role improving the quality and safety of prescribing in long-term care, in particular for those living with advanced dementia. Setting Australian Long-term care pharmacists. Method A qualitative research methodology approach using semi-structured interviews was used, with participants pharmacists with Residential Medication Management Review experience. Interviews were recorded, transcribed and coded utilising a meta-model of Physician-Community Pharmacy Collaboration in medication review. Main outcome measure Pharmacists’ perspectives on the Residential Medication Management Review and how to improve the quality of reviews for residents with advanced dementia. Results Fifteen accredited pharmacists participated. The majority believed that the Residential Medication Management Review had the potential to improve the quality and safety of medicines but highlighted systemic issues that worked against collaborative practice. Participants emphasised the importance of three-way collaboration between general practitioners, pharmacists and nursing staff and highlighted key strategies for its optimisation. Conclusion Incorporating avenues for greater communication between team members can improve collaboration between health professionals and ultimately the quality of medication reviews.

KW - Advanced dementia

KW - Australia

KW - Deprescribing

KW - Interdisciplinary collaboration

KW - Long-term care

KW - Medication review

KW - Palliative care

UR - http://www.scopus.com/inward/record.url?scp=85070060266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070060266&partnerID=8YFLogxK

U2 - 10.1007/s11096-019-00821-7

DO - 10.1007/s11096-019-00821-7

M3 - Article

C2 - 31123899

AN - SCOPUS:85070060266

VL - 41

SP - 950

EP - 962

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 4

ER -